Cyanidin-3-O-Glucoside Modulates the in Vitro Inflammatory Crosstalk between Intestinal Epithelial and Endothelial Cells

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Ferrari, Daniela ^a   Cimino, Francesco ^a   Fratantonio, Deborah ^a   Molonia, Maria Sofia ^a   Bashllari, Romina ^a   Busà, Rossana ^a   Saija, Antonella ^a   Speciale, Antonio ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYANIDIN 3 GLUCOSIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; ANTHOCYANIN; CYANIDIN 3-O-GLUCOSIDE; GLUCOSIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CACO-2 CELL LINE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROTECTION; CELL STIMULATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; INTESTINE EPITHELIUM CELL; LEUKOCYTE ADHERENCE; MODULATION; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOBLOTTING; INTESTINE; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTHOCYANINS; CACO-2 CELLS; E-SELECTIN; ENDOTHELIAL CELLS; EPITHELIAL CELLS; GLUCOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-8; INTESTINES; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85015908318     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2017/3454023     Document Type: Article

References (36)

1. D. I. Sonnier, S. R. Bailey, R. M. Schuster, A. B. Lentsch, and T. A. Pritts, "TNF- induces vectorial secretion of IL-8 in Caco-2 cells," Journal of Gastrointestinal Surgery, vol. 14, no. 10, pp. 1592-1599, 2010.
2. R. J. Mrsny, A. T. Gewirtz, D. Siccardi et al., "Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 19, pp. 7421-7426, 2004.
3. S. Schreiber, S. Nikolaus, and J. Hampe, "Activation of nuclear factor B inflammatory bowel disease," Gut, vol. 42, no. 4, pp. 477-484, 1998.
4. X. Wu, G. R. Beecher, J. M. Holden, D. B. Haytowitz, S. E. Gebhardt, and R. L. Prior, "Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption," Journal of Agricultural and Food Chemistry, vol. 54, no. 11, pp. 4069-4075, 2006.
5. K. Kahle, M. Kraus, W. Scheppach, M. Ackermann, F. Ridder, and E. Richling, "Studies on apple and blueberry fruit constituents: do the polyphenols reach the colon after ingestion" Molecular Nutrition and Food Research, vol. 50,no. 4-5, pp. 418-423, 2006.
6. T. Debnath, D. H. Kim, and B. O. Lim, "Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease," Molecules, vol. 18, no. 6, pp. 7253-7270, 2013.
7. F. Biasi, M. Astegiano, M. Maina, G. Leonarduzzi, and G. Poli, "Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease," Current Medicinal Chemistry, vol. 18, no. 31, pp. 4851-4865, 2011.
8. F. Cimino, C. Balestra, P. Germonpré et al., "Pulsed high oxygen induces a hypoxic-like response in humanumbilical endothelial cells and in humans," Journal of Applied Physiology, vol. 113, no. 11, pp. 1684-1689, 2012.
9. C.Maaser, S. Schoeppner, T.Kucharzik et al., "Colonic epithelial cells induce endothelial cell expression of ICAM-1 andVCAM-1 by a NF-B-dependent mechanism," Clinical and Experimental Immunology, vol. 124, no. 2, pp. 208-213, 2001.
10. D. Ferrari, A. Speciale, M. Cristani et al., "Cyanidin-3-Oglucoside inhibits NF-kB signalling in intestinal epithelial cells exposed toTNF- and exerts protective effects viaNrf2 pathway activation," Toxicology Letters, vol. 264, pp. 51-58, 2016.
11. D. Fratantonio, A. Speciale, D. Ferrari, M. Cristani, A. Saija, and F. Cimino, "Palmitate-induced endothelial dysfunction is attenuated by cyanidin-3-O-glucoside through modulation of Nrf2/Bach1 and NF-B pathways," Toxicology Letters, vol. 239, no. 3, pp. 152-160, 2015.
12. D. Serra, J. Paixão, C. Nunes, T. C. P. Dinis, and L. M. Almeida, "Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid," PLoS ONE, vol. 8, no. 9, Article ID e73001, 2013.
13. J. He, T.C.Wallace, K. E. Keatley, M. L. Failla, andM. M. Giusti, "Stability of black raspberry anthocyanins in the digestive tract lumen and transport efficiency into gastric and small intestinal tissues in the rat," Journal of Agricultural and Food Chemistry, vol. 57, no. 8, pp. 3141-3148, 2009.
14. K. Dehimi, A. Speciale, A. Saija et al., "Antioxidant and antiinflammatory properties of Algerian Thymelaea microphylla Coss. and Dur. extracts," Pharmacognosy Magazine, vol. 12, no. 47, pp. 203-210, 2016.
15. F. Cimino, A. Speciale, S. Anwar et al., "Anthocyanins protect human endothelial cells from mild hyperoxia damage through modulation of Nrf2 pathway," Genes and Nutrition, vol. 8, no. 4, pp. 391-399, 2013.
16. S. Anwar, A. Speciale, D. Fratantonio et al., "Cyanidin-3-Oglucoside modulates intracellular redox status and prevents HIF-1 stabilization in endothelial cells in vitro exposed to chronic hypoxia," Toxicology Letters, vol. 226, no. 2, pp. 206-213, 2014.
17. D. Fratantonio, A. Speciale, R. Canali et al., "Low nanomolar caffeic acid attenuates high glucose-induced endothelial dysfunction in primary human umbilical-vein endothelial cells by affecting NF-B and Nrf2 pathways," BioFactors, vol. 43, no. 1, pp. 54-62, 2017.
18. A. Speciale, S. Anwar, E. Ricciardi, J. Chirafisi, A. Saija, and F. Cimino, "Cellular adaptive response to glutathione depletion modulates endothelial dysfunction triggered by TNF-," Toxicology Letters, vol. 207, no. 3, pp. 291-297, 2011.
19. A. Stucchi, K. Reed, M. O'Brien et al., "A new transcription factor that regulates TNF- gene expression, LITAF, is increased in intestinal tissues frompatients with CD and UC," Inflammatory Bowel Diseases, vol. 12, no. 7, pp. 581-587, 2006.
20. X.Wang and B. Seed, "APCR primer bank for quantitative gene expression analysis," Nucleic Acids Research, vol. 31, article e154, 2003.
21. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCRand the 2T method," Methods, vol. 25, no. 4, pp. 402-408, 2001.
22. A. Speciale, F. Cimino, A. Saija, R. Canali, and F. Virgili, "Bioavailability and molecular activities of anthocyanins as modulators of endothelial function," Genes and Nutrition, vol. 9, no. 4, article no. 404, 2014.
23. D. Tracey, L. Klareskog, E. H. Sasso, J. G. Salfeld, and P. P. Tak, "Tumor necrosis factor antagonist mechanisms of action: a comprehensive review," Pharmacology and Therapeutics, vol. 117, no. 2, pp. 244-279, 2008.
24. A. Speciale, R. Canali, J. Chirafisi, A. Saija, F. Virgili, and F. Cimino, "Cyanidin-3-O-glucoside protection against TNF-induced endothelial dysfunction: involvement of nuclear factor-B signaling," Journal of Agricultural and Food Chemistry, vol. 58, no. 22, pp. 12048-12054, 2010.
25. D. Trombetta, F. Cimino, M. Cristani et al., "In vitro protective effects of two extracts fromBergamot peels on human endothelial cells exposed to tumor necrosis factor- (tnf-)," Journal of Agricultural and Food Chemistry, vol. 58, no. 14, pp. 8430-8436, 2010.
26. S. J. H. vanDeventer, "Review article: chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease" Alimentary Pharmacology and Therapeutics, vol. 11, supplement 3, pp. 116-121, 1997.
27. G. Muzes, B. Molnár, Z. Tulassay, and F. Sipos, "Changes of the cytokine profile in inflammatory bowel diseases," World Journal of Gastroenterology, vol. 18, no. 41, pp. 5848-5861, 2012.
28. D.-Y. Ren, C. Li, Y.-Q.Qinet al., "Lactobacilli reduce chemokine IL-8 production in response to TNF- and Salmonella challenge of Caco-2 cells," BioMed Research International, vol. 2013, Article ID 925219, 9 pages, 2013.
29. L. Antoni, S. Nuding, J. Wehkamp, and E. F. Stange, "Intestinal barrier in inflammatory bowel disease," World Journal of Gastroenterology, vol. 20, no. 5, pp. 1165-1179, 2014.
30. W. E. Cromer, J. M. Mathis,D.N. Granger,G.V. Chaitanya, and J. S. Alexander, "Role of the endotheliumin inflammatory bowel diseases," World Journal of Gastroenterology, vol. 17, no. 5, pp. 578-593, 2011.
31. V. Taverniti, D. Fracassetti, C. Del Bo' et al., "Immunomodulatory effect of a wild blueberry anthocyanin-rich extract in human caco-2 intestinal cells," Journal of Agricultural and Food Chemistry, vol. 62, no. 33, pp. 8346-8351, 2014.
32. C. Nunes, E. Ferreira, V. Freitas, L. Almeida, R. M. Barbosa, and J. Laranjinha, "Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells," Food and Function, vol. 4, no. 3, pp. 373-383, 2013.
33. D. K. Gessner, A. Fiesel, E. Most et al., "Supplementation of a grape seed and grape marc meal extract decreases activities of the oxidative stress-responsive transcription factorsNF-kappaB and Nrf2 in the duodenal mucosa of pigs," Acta Veterinaria Scandinavica, vol. 55, article 18, 2013.
34. A. Cuadrado, Z. Martín-Moldes, J. Ye, and I. Lastres-Becker, "Transcription factors NRF2 and NF-B are coordinated effectors of the rho family, GTP-binding protein RAC1 during Inflammation," Journal of Biological Chemistry, vol. 289, no. 22, pp. 15244-15258, 2014.
35. C. Abraham and J. H. Cho, "Inflammatory bowel disease," New England Journal of Medicine, vol. 361, no. 21, pp. 2066-2078, 2009.
36. A. Speciale, S. Anwar, R. Canali et al., "Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway," Molecular Nutrition and Food Research, vol. 57, no. 11, pp. 1979-1987, 2013.